Wellcome Sanger Institute. Cancer Genome Project R&D Centre

The Cancer Genome Project uses high-throughput genome sequencing to identify these somatically acquired mutations with the aim of characterising cancer genes, mutational processes and patterns of clonal evolution in human tumours.

Headquarters: United Kingdom